LYKA LABS
Back to Income Statement
|
LYKA LABS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹128 Cr | ₹138 Cr | ₹111 Cr | ₹93 Cr | ₹194 Cr |
What is the latest Revenue of LYKA LABS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹128 Cr |
| Mar2025 | ₹138 Cr |
| Mar2024 | ₹111 Cr |
| Mar2023 | ₹93 Cr |
| Mar2022 | ₹194 Cr |
How is Revenue of LYKA LABS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹128 Cr | -7.26 | |
| Mar2025 | ₹138 Cr | 24.55 | |
| Mar2024 | ₹111 Cr | 19.47 | |
| Mar2023 | ₹93 Cr | -52.05 | |
| Mar2022 | ₹194 Cr | - | |
Compare Revenue of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹264.3 Cr | -0.6% | 22% | -25.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -0.6% |
22% |
-25.8% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses